Author Details :
Volume : 7, Issue : 1, Year : 2020
Article Page : 71-75
Introduction: The gestational trophoblastic disease (GTD) is a group of pregnancy related tumours
encompassing complete and partial mole, invasive moles, choriocarcinomas and placental site trophoblastic
tumours. Amongst all GTD, hydatidiform moles are the most common form. Hydatidiform mole is a
relatively common gynecological condition which could presents like spontaneous abortion, one of the
most common gynecological emergencies.
Materials and Methods: Present study is a retrospective analysis to determine incidence of hydatidiform
mole for eight years duration.All women who were diagnosed of molar pregnancy by estimation of beta
hCG and histopathological examination during1st Jan 2010 to 31st Dec 2017 were enrolled in this study.
During the study period, there were 84 cases of Molar pregnancy out of 33856 total deliveries.
Results: The total number of deliveries reported in the study period was 33856 out of which 84 cases were
of gestational trophoblastic disease (GTD). The prevalence of GTD in this tertiary care hospital was 2.48
per 1000 deliveries. During the study period, we had received 55 samples of products of conception and
3079 hysterectomy specimens. Out of 3134 cases, 84 cases were diagnosed as GTD. Out of these 84 cases
81cases were hydatidiform mole. There were two cases of choriocarcinomas and one case of placental site
Conclusion: The prevalence of hydatidiform mole was higher among all entities of gestational
trophoblastic disease. The serum beta hCG levels are very sensitive and specific for diagnosis.
Histopathological examination is helpful for confirming diagnosis.
Keywords: Molar, Hydatidiform mole, Trophoblast.
How to cite : Patil B U, Gangane N M, Shivkumar V B, The frequency of hydatidiform mole in a tertiary care hospital from central India. Indian J Pathol Oncol 2020;7(1):71-75
Copyright © 2020 by author(s) and Indian J Pathol Oncol. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)